| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_08c27a78e03c77dc27379d4bb61cfd6f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H13-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H13-04 |
| filingDate |
2012-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51032bf7ffe1dd96f808159eea002f17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_967259659b3f6e71d5a5e956d659faae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e57277d9b1f2a08d49beffbb365a4974
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_518c89c6eae3191949f7c69b847b6a30 |
| publicationDate |
2015-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
IN-2014MN01750-A |
| abstract |
The present invention relates to a process for the synthesis of the Factor Xa anticoagulent Fondaparinux and related compounds. The invention relates in addition to efficient and scalable processes for the synthesis of various intermediates useful in the synthesis of Fondaparinux and related compounds. |
| priorityDate |
2012-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |